nach oben

Journal of Inherited Metabolic Disease

Erschienen in:

01.09.2014 | ICIEM Symposium 2013

Inborn errors of purine metabolism: clinical update and therapies

verfasst von: Shanti Balasubramaniam, John A. Duley, John Christodoulou

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Inborn errors of purine metabolism exhibit broad neurological, immunological, haematological and renal manifestations. Limited awareness of the phenotypic spectrum, the recent descriptions of newer disorders and considerable genetic heterogeneity, have contributed to long diagnostic odysseys for affected individuals. These enzymes are widely but not ubiquitously distributed in human tissues and are crucial for synthesis of essential nucleotides, such as ATP, which form the basis of DNA and RNA, oxidative phosphorylation, signal transduction and a range of molecular synthetic processes. Depletion of nucleotides or accumulation of toxic intermediates contributes to the pathogenesis of these disorders. Maintenance of cellular nucleotides depends on the three aspects of metabolism of purines (and related pyrimidines): de novo synthesis, catabolism and recycling of these metabolites. At present, treatments for the clinically significant defects of the purine pathway are restricted: purine 5′-nucleotidase deficiency with uridine; familial juvenile hyperuricaemic nephropathy (FJHN), adenine phosphoribosyl transferase (APRT) deficiency, hypoxanthine phosphoribosyl transferase (HPRT) deficiency and phosphoribosyl-pyrophosphate synthetase superactivity (PRPS) with allopurinol; adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) deficiencies have been treated by bone marrow transplantation (BMT), and ADA deficiency with enzyme replacement with polyethylene glycol (PEG)-ADA, or erythrocyte-encapsulated ADA; myeloadenylate deaminase (MADA) and adenylosuccinate lyase (ADSL) deficiencies have had trials of oral ribose; PRPS, HPRT and adenosine kinase (ADK) deficiencies with S-adenosylmethionine; and molybdenum cofactor deficiency of complementation group A (MOCODA) with cyclic pyranopterin monophosphate (cPMP). In this review we describe the known inborn errors of purine metabolism, their phenotypic presentations, established diagnostic methodology and recognised treatment options.

Abruscia P, Chiarellia L, Galizzi A et al (2007) Erythrocyte adenylate kinase deficiency: characterization of recombinant mutant forms and relationship with nonspherocytic hemolytic anemia. Exp Hematol 35(8):1182–1189

Ahmed M, Taylor W, Smith PR, Becker MA (1999) Accelerated transcription of PRPS1 in X-linked overactivity of normal human phosphoribosylpyrophosphate synthetase. J Biol Chem 274:7482–7488PubMed

Aiuti A, Cattaneo F, Galimberti S et al (2009) Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 360:447–458PubMed

Arredondo-Vega FX, Santisteban I, Shannon Daniels S, Toutai S, Hershfield MS (1998) Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles. Am J Hum Genet 63:1049–1059PubMedCentralPubMed

Arts WF, Loonen MC, Sengers RC, Slooff JL (1993) X-linked ataxia, weakness, deafness, and loss of vision in early childhood with a fatal course. Ann Neurol 33:535–539PubMed

Baguette C, Vermylen C, Brichard B et al (2002) Persistent developmental delay despite successful bone marrow transplantation for purine nucleoside phosphorylase deficiency. J Pediatr Hematol Oncol 24:69–71PubMed

Bakker JA, Bierau J (2012) Purine and pyrimidine metabolism: still more to learn. Ned Tijdschr Klin Chem Labgeneesk 37:3–6. http://www.nvkc.nl/publicaties/documents/2012-1-p3-p6.pdf

Barić I (2009) Inherited disorders in the conversion of methionine to homocysteine. J Inherit Metab Dis 32(4):459–471PubMed

Bax BE, Bain MD, Fairbanks LD et al (2007) A 9-yr evaluation of carrier erythrocyte encapsulated adenosine deaminase (ADA) therapy in a patient with adult-type ADA deficiency. Eur J Haematol 79:338–48PubMed

Becker MA (2001) Phosphoribosylpyrophosphate synthetase and the regulation of phosphoribosylpyrophosphate production in human cells. Prog Nucleic Acid Res Mol Biol 69:115–148PubMed

Bhasin B, Stiburkova B, De Castro-Pretelt M et al (2014) Hereditary renal hypouricemia: a new role for allopurinol? Am J Med 127(1):e3–4, epubPubMed

Bjursell MK, Blom HJ, Cayuela JA et al (2011) Adenosine kinase deficiency disrupts the methionine cycle and causes hypermethioninemia, encephalopathy, and abnormal liver function. Am J Hum Genet 89(4):507–515PubMedCentralPubMed

Bleyer AJ, Zivna M, Hulkova H et al (2010) Clinical and molecular characterisation of a family with a dominant renin gene mutation and response to treatment with fludricortisone. Clin Nephrol 74(6):411–422PubMed

Boivin P, Galand C, Hakim J, Simony D, Seligman M (1971) A new erythroenzymopathy: congenital non-spherocytic hemolytic anemia and hereditary erythrocytic adenylate kinase deficiency. Presse Med 79:215–218PubMed

Bollée G, Dollinger C, Boutaud L et al (2010) Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency. J Am Soc Nephrol 21:679–688PubMedCentralPubMed

Bollée G, Dahan K, Flamant M et al (2011) Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations. Clin J Am Soc Nephrol 6(10):2429–2438PubMedCentralPubMed

Boria I, Garelli E, Gazda HT et al (2010) The ribosomal basis of diamond-blackfan anemia: mutation and database update. Hum Mutat 34:1269–1279

Bottiglieri T (2002) S-adenosyl-L-methionine (SAMe): from the bench to the bedside—molecular basis of a pleiotrophic molecule. Am J Clin Nutr 76:1151S–1157SPubMed

Bowne SJ, Sullivan LS, Blanton SH et al (2002) Mutations in the inosine monophosphate dehydrogenase 1 gene (IMPDH1) cause the RP10 form of autosomal dominant retinitis pigmentosa. Hum Mol Genet 11:559–568PubMedCentralPubMed

Bowne SJ, Sullivan LS, Mortimer SE et al (2006) Spectrum and frequency of mutations in IMPDH1 associated with autosomal dominant retinitis pigmentosa and leber congenital amaurosis. Invest Ophthalmol Vis Sci 47:34–42PubMedCentralPubMed

Broome CB, Graham ML, Saulsbury FT et al (1996) Correction of purine nucleoside phosphorylase deficiency by transplantation of allogeneic bone marrow from a sibling. J Pediatr 128:373–376PubMed

Bruce CK, Smith M, Rahman F et al (2010) Design and validation of a metabolic disorder resequencing microarray (BRUM1). Hum Mutat 31:858–865PubMed

Bruyland M, Ebinger G (1994) Beneficial effect of a treatment with xylitol in a patient with myoadenylate deaminase deficiency. Clin Neuropharmacol 17(5):492–493PubMed

Buchaklian AH, Helbling D, Ware SM, Dimmock DP (2012) Recessive deoxyguanosine kinase deficiency causes juvenile onset mitochondrial myopathy. Mol Genet Metab 107:92–94PubMed

Cameron JS, Moro F, Simmonds HA (1993) Gout, uric acid and purine metabolism in paediatric nephrology. Pediatr Nephrol 7:105–118PubMed

Camici M, Micheli V, Ipata PL, Tozzi MG (2010) Pediatric neurological syndromes and inborn errors of purine metabolism. Neurochem Int 56(3):367–378PubMed

Carpenter PA, Ziegler JB, Vowels MR (1996) Late diagnosis and correction of purine nucleoside phosphorylase deficiency with allogeneic bone marrow transplantation. Bone Marrow Transplant 17:121–124PubMed

Chen BC, Balasubramaniam S, McGown IN, et al (2013) Treatment of Lesch–Nyhan disease with S-adenosylmethionine: Experience with five young Malaysians, including a girl. Brain Dev. Sep 18 [epub]

Christen HJ, Hanefeld F, Duley JA, Simmonds HA (1992) Distinct neurological syndrome in two brothers with hyperuricaemia. Lancet 340:1167–1168PubMed

Chu SY, Cashion P, Jiang M (1989) Purine nucleoside phosphorylase in erythrocytes: determination of optimum reaction conditions. Clin Biochem 22:3–9PubMed

de Brouwer APM, Williams KL, Duley JA et al (2007) Arts syndrome is caused by loss-of-function mutations in PRPS1. Am J Hum Genet 81:507–518PubMedCentralPubMed

de Brouwer APM, van Bokhoven H, Nabuurs SB, Arts WF, Christodoulou J, Duley J (2010) PRPS1 mutations: four distinct syndromes and potential treatment. Am J Hum Genet 86:506–518PubMedCentralPubMed

Delicou S, Kitra-Roussou V, Peristeri J (2007) Successful HLA-identical hematopoietic stem cell transplantation in a patient with purine nucleoside phosphorylase deficiency. Pediatr Transplant 11:799–803PubMed

Dimmock DP, Zhang Q, Dionisi-Vici C et al (2007) Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinase. Hum Mutat 29:330–331

Dolcetta D, Parmigiani P, Salmaso L et al (2013) Quantitative evaluation of the clinical effects of S-adenosylmethionine on mood and behavior in Lesch-Nyhan patients. Nucleosides Nucleotides Nucleic Acids 32(4):174–188PubMed

Duley JA, Christodoulou J, de Brouwer APM (2011) The PRPP synthetase spectrum: what does it demonstrate about nucleotide syndromes? Nucleosides. Nucleotides Nucleic Acids 30(12):1129–1139

Duran M, Dorland L, Meuleman EE, Allers P, Berger R (1997) Inherited defects of purine and pyrimidine metabolism: laboratory methods for diagnosis. J Inherit Metab Dis 20:227–236PubMed

Enomoto A, Kimura H, Chairoungdua A et al (2002) Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417:447–452PubMed

Fargo JH, Kratz CP, Giri N et al (2013) Erythrocyte adenosine deaminase: diagnostic value for diamond-blackfan anaemia. Br J Haematol 160:547–554PubMedCentralPubMed

Fischer A, Landais P, Friedrich W et al (1990) European experience of bone-marrow transplantation for severe combined immunodeficiency. Lancet 336:850–854PubMed

Fishbein WN, Armbrustmacher VW, Griffin JL (1978) Myoadenylate deaminase deficiency: a new disease of muscle. Science 200:545–548

Fu R, Ceballos-Picot I, Torres RJ, Group L-NDIS et al (2014) Genotype-phenotype correlations in neurogenetics: Lesch-Nyhan disease as a model disorder. Brain 137(5):1282–303PubMed

Gaspar HB (2012) Gene therapy for ADA-SCID: defining the factors for successful outcome. Blood 120:3628–3629PubMed

Gaspar HB, Bjorkegren E, Parsley K et al (2006) Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning. Mol Ther 14:505–513PubMed

Gaspar HB, Aiuti A, Porta F, Candotti F, Hershfield MS, Notarangelo LD (2009) How I treat ADA deficiency. Blood 114:3524–3532PubMedCentralPubMed

Giblett ER, Anderson JE, Cohen F, Pollara B, Meuwissen HJ (1972) Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 2(7786):1067–1069PubMed

Giblett ER, Amman AJ, Wara DW, Diamond LK (1975) Nucleoside phosphorylase deficiency in a child with severely defective T cell immunity and normal B cell immunity. Lancet 1(7914):1010–1013PubMed

Glader BE, Backer K, Diamond LK (1983) Elevated erythrocyte adenosine deaminase activity in congenital hypoplastic anemia. N Engl J Med 309:1486–1490PubMed

Glick N (2006) Dramatic reduction in self-injury in Lesch–Nyhan disease following S-adenosylmethionine administration. J Inherit Metab Dis 29:687PubMed

Grabhorn E, Tsiakas K, Herden U et al (2014) Long-term outcome after liver transplantation for deoxyguanosine kinase deficiency. A single-center experience and a review of the literature. Liver Transpl 20(4):464–472PubMed

Harambat J, Bollée G, Daudon M et al (2012) Adenine phosphoribosyltransferase deficiency in children. Pediatr Nephrol 27:571–579PubMed

Henderson LA, Francesco F, Hopkins G et al (2013) First reported case of Omenn syndrome in a patient with reticular dysgenesis. J Allergy Clin Immunol 131(4):1227–1230PubMedCentralPubMed

Hershfield MS, Mitchell BS (1995) Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 7th edn. McGraw-Hill, New York, pp 1725–1768

Hershfield MS, Buckley RH, Greenberg ML et al (1987) Treatment of adenosine deaminase deficiency with polyethylene glycol modified adenosine deaminase. N Engl J Med 316:589–596PubMed

Horiguchi T, Fuka M, Fujisawa K et al (2014) Adenylate kinase 2 deficiency limits survival and regulates various genes during larval stages of Drosophilia melanogaster. J Med Investig 61:137–150

Horikawa Y, Iwasaki N, Hara M et al (1997) Mutation in hepatocyte nuclear factor-1-beta gene (TCF2) associated with MODY. Nat Genet 17:384–385PubMed

Ipata PL, Camici M, Micheli V, Tozz MG (2011) Metabolic network of nucleosides in the brain. Curr Top Med Chem 11(8):909–22PubMed

Jaeken J, Wadman SK, Duran M et al (1988) Adenylosuccinase deficiency: an inborn error of purine nucleotide synthesis. Eur J Pediatr 148:126–131PubMed

Jinnah HA, Ceballos-Picot I, Torres RJ, Group L-NDIS et al (2010) Attenuated variants of Lesch-Nyhan disease. Brain 133:671–689PubMedCentralPubMed

Johnson JL, Duran M (2001) Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency. In: Scriver C, Beaudet A, Sly W, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 3163–3177

Jurecka A (2009) Inborn errors of purine and pyrimidine metabolism. J Inherit Metab Dis 32:247–263PubMed

Jurecka A, Zikanova M, Tylki-Szymanska A et al (2008) Clinical, biochemical and molecular findings in seven polish patients with adenylosuccinate lyase deficiency. Mol Genet Metab 94:435–442PubMed

Kelley RE, Andersson HC (2014) Disorders of purines and pyrimidines. Handb Clin Neurol 120:827–38PubMed

Kelley WN, Rosenbloom FM, Henderson JF, Seegmiller JE (1967) A specific enzyme defect in gout associated with overproduction of uric acid. Proc Natl Acad Sci U S A 57:1735–1739PubMedCentralPubMed

Kennan A, Aherne A, Palfi A et al (2002) Identification of an IMPDH1 mutation in autosomal dominant retinitis pigmentosa (RP10) revealed following comparative microarray analysis of transcripts derived from retinas of wild-type and Rho(−/−) mice. Hum Mol Genet 11:547–557PubMed

Kim HJ, Sohn KM, Shy ME et al (2007) Mutations in PRPS1, which encodes the phosphoribosyl pyrophosphate synthetase enzyme critical for nucleotide biosynthesis, cause hereditary peripheral neuropathy with hearing loss and optic neuropathy (cmtx5). Am J Hum Genet 81:552–558PubMedCentralPubMed

Kirby A, Gnirke A, Jaffe DB et al (2013) Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Nat Genet 45:299–303

Köttgen A, Albrecht E, Teumer A et al (2013) Genome-wide association analyses identify 18 new loci. Nat Genet 45(2):145–154PubMedCentralPubMed

Lagresle-Peyrou C, Six EM, Picard C et al (2009) Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness. Nat Genet 41:106–111PubMedCentralPubMed

Lui X, Han D, Li J et al (2009) Loss-of function mutations in the PRPS1 gene cause a type of nonsyndromic X-linked sensorineural deafness, DFN2. Am J Hum Genet 8:65–71

Lundy CT, Jungbluth H, Pohl KR et al (2010) Adenylosuccinate lyase deficiency in the united kingdom pediatric population: first three cases. Pediatr Neurol 43(5):351–354PubMed

Marie S, Heron B, Bitoun P, Timmerman T, Van Den Berghe G, Vincent MF (2004) AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC. Am J Hum Genet 74:1276–1281PubMedCentralPubMed

Markert ML (1991) Purine nucleoside phosphorylase deficiency. Immunodefic Rev 3:45–81PubMed

Moore KJ, Tabas I (2011) Macrophages in the pathogenesis of atherosclerosis. Cell 145:341–55PubMedCentralPubMed

Morisaki T, Gross M, Morisaki H, Pongratz D, Zollner N, Holmes EW (1992) Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc Natl Acad Sci U S A 89:6457–6461PubMedCentralPubMed

Mouchegh K, Zikánová M, Hoffmann GF et al (2007) Lethal fetal and early neonatal presentation of adenylosuccinate lyase deficiency: observation of 6 patients in 4 families. J Pediatr 150:57–61PubMed

Navon Elkan P, Pierce SB, Segel R et al (2014) Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. New Eng J Med 370:921–931PubMed

Ng SB, Buckingham KJ, Lee C et al (2010) Exome sequencing identifies the cause of a Mendelian disorder. Nat Genet 42(1):30–35PubMedCentralPubMed

Nicoletta JA, Lande MB (2006) Medical evaluation and treatment of urolithiasis. Pediatr Clin N Am 53:479–491

Noma T (2005) Dynamics of nucleotide metabolism as a supporter of life phenomena. J Med Investig 52(3–4):127–136

Nyhan WL, O’Neill JP, Jinnah HA, Harris JC et al (2014) Lesch-Nyhan syndrome. In: Pagon RA (ed) GeneReviews [Internet]. University of Washington, Seattle, pp 1993–2014, http://www.ncbi.nlm.nih.gov/books/NBK1149/

Ogasawara N, Goto H, Yamada Y et al (1987) Deficiency of AMP deaminase in erythrocytes. Hum Genet 75:15–18PubMed

Page T, Yu A, Fontanesi J, Nyhan WL (1997) Developmental disorder associated with increased cellular nucleotidase activity. Proc Natl Acad Sci U S A 94:11601–11606PubMedCentralPubMed

Pannicke U, Hönig M, Hess I et al (2009) Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. Nat Genet 41:101–105PubMed

Pesi R, Micheli V, Jacomelli G et al (2000) Cytosolic 5′-nucleotidase hyperactivity in erythrocytes of Lesch–Nyhan syndrome patients. Neuroreport 11:1827–1831PubMed

Pinto CS, Seifert R (2006) Decreased GTP-stimulated adenylylcyclase activity in HPRT-deficient human and mouse fibroblast and ratB103 neuroblastoma cell membranes. J Neurochem 96:454–459PubMed

Piret SE, Danoy P, Dahan K et al (2011) Genome-wide study of familial juvenile hyperuricaemic (gouty) nephropathy (FJHN) indicates a new locus, FJHN3, linked to chromosome 2p22.1-p21. Hum Genet 129(1):51–58PubMed

Puig JG, Torres RJ, Mateos FA et al (2001) The spectrum of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. Clinical experience based on 22 patients from 18 Spanish families. Medicine 80:102PubMed

Raivio KO, Saksela M, Lapatto R (2001) Xanthine oxidoreductase: role in human pathophysiology and in hereditary xanthinuria. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 2639–2652

Rijksen G, Kuis W, Wadman SK et al (1967) A new case of purine nucleoside phosphorylase deficiency: enzymologic, clinical, and immunologic characteristics. Pediatr Res 21(2):137–141

Rosenberg RN, Chutorian A (1967) Familial opticoacoustic nerve degeneration and polyneuropathy. Neurology 17:827–832PubMed

Salerno C, D’Eufemia P, Finocchiaro R et al (1999) Effect of D-ribose on purine synthesis and neurological symptoms in a patient with adenylosuccinase deficiency. Biochim Biophys Acta 1453:135–140PubMed

Simmonds HA, van Gennip AH (2003) Purine and pyrimidine disorders. In: Blau N, Duran M, BlaskovicsM GKM (eds) Physician’s guide to the laboratory diagnosis of metabolic diseases. Springer, Heidelberg, Berlin, pp 445–465

Simmonds HA, Watson AR, Webster DR et al (1982) GTP depletion and other erythrocyte abnormalities in inherited PNP deficiency. Biochem Pharmacol 15:31(6):941

Simmonds HA, Reiter S, Davies PM, Cameron JS (1991) Orotidine accumulation in human erythrocytes during allopurinol therapy: association with high urinary oxypurinol-7-riboside concentrations in renal failure and in the Lesch–Nyhan syndrome. Clin Sci (Lond) 80:191–7

Simmonds HA, Reiter S, Nishino T (1995) Hereditary xanthinuria. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, vol 2. McGraw-Hill, New York, p p1781

Simmonds HA, Duley JA, Fairbanks LD, McBride MB (1997) When to investigate for purine and pyrimidine disorders. Introduction and review of clinical and laboratory indications. J Inherit Metab Dis 20:214–226PubMed

Spiegel EK, Colman RF, Patterson D (2006) Adenylosuccinate lyase deficiency. Mol Genet Metab 89:19–31PubMed

Spinazzola A, Invernizzi F, Carrara F et al (2009) Clinical and molecular features of mitochondrial DNA depletion syndromes. J Inherit Metab Dis 32:143–158PubMed

Stephan JL, Vlekova V, Le Deist F et al (1993) Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr 123:564–572PubMed

Stow RA, Bronk JR (1993) Purine nucleoside transport and metabolism in isolated rat jejunum. J Physiol 468:311–324PubMedCentralPubMed

Sumi S, Marinaki AM, Arenas M et al (2002) Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency. Hum Genet 111:360–367PubMed

Tam DA, Leshner RT (1995) Stroke in purine nucleoside phosphorylase deficiency. Pediatr Neurol 12:146–148PubMed

Tanaka C, Hara T, Suzaki I et al (1996) Sensorineural deafness in siblings with adenosine deaminase deficiency. Brain Dev 18:304–306PubMed

Toren A, Brok-Simoni F, Ben-Bassat I et al (1994) Congenital haemolytic anemia associated with adenylate kinase deficiency. Br J Haematol 87(2):376–380PubMed

Torres RJ, Prior C, Puig JG (2007) Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency. Metabolism 56(9):1179–86PubMed

Trifilo M, Page T (2000) NAPDD patients exhibit altered electrophoretic mobility of cytosolic 50-nucleotidase. Adv Exp Med Biol 486:87–90PubMed

Valentine WN, Paglia DE, Tartaglia AP, Gilsanz F (1977) Hereditary hemolytic anemia with increased red cell adenosine deaminase (45- to 70-fold) and decreased adenosine triphosphate. Science 195:783–785PubMed

van den Berghe G, Hers HG (1980) Abnormal AMP deaminase in primary gout. Lancet 316:1090

van den Berghe G, Vincent MF, Sandrine M (2012) Disorders of purine and pyrimidine metabolism. In: Saudubray JM, van der Berghe G, Walter J (eds) Inborn metabolic diseases: diagnosis and treatment, vol 5th. Springer, Berlin, pp 500–518

van Gennip AH (1999) Defects in metabolism of purines and pyrimidines. Ned Tijdschr Klin Chem 24:171–175, http://www.nvkc.nl/tijdschrift/content/1999/nr%203/p171/1999-3-p171.pdf

van Werkhoven MA, Duley JA, McGown I, Munce T, Freeman JL, Pitt JJ (2013) Early diagnosis of adenylosuccinate lyase deficiency using a high-throughput screening method and a trial of oral S-adenosyl-l-methionine as a treatment method. Dev Med Child Neurol 55(11):1060–1064PubMed

Veldman A, Santamaria-Araujo JA, Sollazzo S et al (2010) Successful treatment of molybdenum cofactor deficiency type a with cPMP. Pediatrics 125:e1249–e1254PubMed

Vitart V, Rudan I, Hayward C et al (2008) SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 40:437–442PubMed

Woodward OM, Köttgen A, Coresh J, Boerwinkle E, Guggino WB, Köttgen M (2009) Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci USA 106:10338–10342

Woollard KJ, Geissmann F (2010) Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 7:77–86PubMedCentralPubMed

Zamzami MA, Duley JA, Price GR et al (2013) Inosine triphosphate pyrophosphohydrolase (ITPA) polymorphic sequence variants in adult hematological malignancy patients and possible association with mitochondrial DNA defects. J Hematol Oncol. 6:e24

Zhou Q, Yang D, Ombrello AK et al (2014) Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med 370(10):911–920PubMed

Zivna M, Hulkova H, Matignon M et al (2009) Dominant renin gene mutations associated with early-onset hyperuricemia, anemia, and chronic kidney failure. Am J Hum Genet 85:204–213PubMedCentralPubMed

Zollner N, Reiter S, Gross M et al (1986) Myoadenylate deaminase deficiency: successful symptomatic therapy by high dose oral administration of ribose. Klin Wochenschr 64:1281–1290PubMed

Titel: Inborn errors of purine metabolism: clinical update and therapies
verfasst von: Shanti Balasubramaniam
John A. Duley
John Christodoulou
Publikationsdatum: 01.09.2014
Verlag: Springer Netherlands
Erschienen in: Journal of Inherited Metabolic Disease / Ausgabe 5/2014
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI: https://doi.org/10.1007/s10545-014-9731-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2014

Combined D2-/L2-hydroxyglutaric aciduria (SLC25A1 deficiency): clinical course and effects of citrate treatment

Genistein increases glycosaminoglycan levels in mucopolysaccharidosis type I cell models

Experimental evidence for protein oxidative damage and altered antioxidant defense in patients with medium-chain acyl-CoA dehydrogenase deficiency

Clinical presentation and outcome in a series of 88 patients with the cblC defect

Unravelling the complex MRI pattern in glutaric aciduria type I using statistical models—a cohort study in 180 patients

Effects of hematopoietic stem cell transplantation on acyl-CoA oxidase deficiency: a sibling comparison study